Target intelligence / Profile preview

Sirtuin 2 (None)

Target
None
Molecular classification
Enzyme, Histone modification, NAD+-dependent protein deacetylase, NAD+-dependent histone deacetylase
01

Overview

Sirtuin 2 (SIRT2) is a member of the sirtuin family of proteins, which are NAD+-dependent deacetylases and ADP-ribosyltransferases. It plays roles in cellular regulation, metabolism, aging, and disease. It is primarily cytosolic but also found in the nucleus during certain cell cycle phases. SIRT2 exerts multiple regulatory functions, including NAD+-dependent lysine deacetylase activity and mono ADP-ribosyltransferase activity. It regulates microtubule dynamics, myelination control, gluconeogenesis, chromatin compaction, and DNA damage response. SIRT2 modulates autophagy/mitophagy and is implicated as both a tumor suppressor or promoter depending on context. It is a potential therapeutic target for age-related disorders including cancer/metabolic syndrome/neurodegeneration.

02

Mechanism of action

Binding NAD+ at its catalytic core, deacetylating substrate lysines via an ADPR peptidyl-imidate intermediate, and releasing nicotinamide from NAD+, transferring acetyl group from substrate to form O-acetyl ADP ribose plus deacetylated protein product.

03

Biological functions

Cell cycleMicrotubule acetylation/deacetylationMyelination controlGluconeogenesis regulationChromatin compactionDNA damage responseAutophagyMitophagyRegulation of protein function via deacetylationMetabolic regulation
04

Disease associations

Neurodegenerative diseaseAlzheimer's diseaseCancerMetabolic syndrome
05

Safety considerations

Context-dependent tumor suppressor or promoter activityPotential for divergent effects of modulators based on cellular context
06

Interacting drugs

AK-1

1 more in the full profile.

Beyond the preview

Go deeper on Sirtuin 2 (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sirtuin 2 (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call